Found: 19
Select item for more details and to access through your institution.
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep06828
- By:
- Publication type:
- Article
Undescribed Case of Necrotic Ulcerative Amyopathic Dermatomyositis in Bone Metastatic Breast Cancer.
- Published in:
- Breast Journal, 2008, v. 14, n. 6, p. 591, doi. 10.1111/j.1524-4741.2008.00654.x
- By:
- Publication type:
- Article
Efficacy and Tolerability of Biweekly Bevacizumab, Irinotecan, Folinic Acid and Fluorouracil Intravenous Bolus (BIFF Regimen) in Patients With Metastatic Colorectal Cancer: The Southern Italy Cooperative Oncology Group Experience.
- Published in:
- Clinical Colorectal Cancer, 2011, v. 10, n. 1, p. 42, doi. 10.3816/CCC.2011.n.006
- By:
- Publication type:
- Article
Dose-Dense Primary Chemotherapy, as Part of Multidisciplinary Treatment, for Inoperable Stage III B Breast Cancer – Long-Term Results of a Phase II Trial.
- Published in:
- Oncology, 2007, v. 72, n. 1/2, p. 17, doi. 10.1159/000111084
- By:
- Publication type:
- Article
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting.
- Published in:
- Oncologist, 2017, v. 22, n. 6, p. 648, doi. 10.1634/theoncologist.2016-0461
- By:
- Publication type:
- Article
Long-Term Outcomes in Stage IIIB Breast Cancer Patients Who Achieved Less Than a Pathological Complete Response (<pCR) After Primary Chemotherapy.
- Published in:
- Oncologist, 2009, v. 14, n. 11, p. 1051, doi. 10.1634/theoncologist.2009-0077
- By:
- Publication type:
- Article
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47627-1
- By:
- Publication type:
- Article
Allergy and Tumour Outcome after Primary Cancer Therapy.
- Published in:
- International Archives of Allergy & Immunology, 2004, v. 133, n. 2, p. 174, doi. 10.1159/000076624
- By:
- Publication type:
- Article
Inflammatory Breast Cancer in Italy.
- Published in:
- Cancer (0008543X), 2010, v. 116, p. 2736, doi. 10.1002/cncr.25164
- By:
- Publication type:
- Article
Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1392-9
- By:
- Publication type:
- Article
Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 383, doi. 10.1186/s12885-015-1392-9
- By:
- Publication type:
- Article
Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Hypothyroidism and Thyroid Autoimmunity as a Prognostic Biomarker of Better Response in Metastatic Cancer Long-Term Survivors Treated with Sunitinib.
- Published in:
- Thyroid, 2016, v. 26, n. 9, p. 1336, doi. 10.1089/thy.2016.0159
- By:
- Publication type:
- Article
Thyroid Dysfunction in Patients with Metastatic Carcinoma Treated with Sunitinib: Is Thyroid Autoimmunity Involved?
- Published in:
- Thyroid, 2015, v. 25, n. 11, p. 1255, doi. 10.1089/thy.2015.0170
- By:
- Publication type:
- Article
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma.
- Published in:
- Oncology Letters, 2016, v. 12, n. 2, p. 1415, doi. 10.3892/ol.2016.4798
- By:
- Publication type:
- Article
Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia.
- Published in:
- Oncology Letters, 2014, v. 7, n. 4, p. 948, doi. 10.3892/ol.2014.1834
- By:
- Publication type:
- Article
Targeting insulin-like growth factor type 1 receptor in cancer therapy.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study.
- Published in:
- Journal of Translational Medicine, 2016, v. 14, p. 1, doi. 10.1186/s12967-016-1053-z
- By:
- Publication type:
- Article